Regarding DFS time in the TCGA tumor types, data showed that UBE2C higher-expression levels led to worse DFS prognosis in comparison to its lower expression in the following tumors: ACC, KIRC, KIRP, LGG, LIHC, PAAD, PRAD, THCA, and UCEC. This evidence concerns the gene UBE2C and neoplasm.